Exercise training improves vascular function in patients with Alzheimer's disease.


Journal

European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 10 04 2020
accepted: 19 07 2020
pubmed: 31 7 2020
medline: 2 7 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

Vascular dysfunction has been demonstrated in patients with Alzheimer's disease (AD). Exercise is known to positively affect vascular function. Thus, the aim of our study was to investigate exercise-induced effects on vascular function in AD. Thirty-nine patients with AD (79 ± 8 years) were recruited and randomly assigned to exercise training (EX, n = 20) or control group (CTRL, n = 19). All subjects performed 72 treatment sessions (90 min, 3 t/w). EX included moderate-high-intensity aerobic and strength training. CTRL included cognitive stimuli (visual, verbal, auditive). Before and after the 6-month treatment, the vascular function was measured by passive-leg movement test (PLM, calculating the variation in blood flow: ∆peak; and area under the curve: AUC) tests, and flow-mediated dilation (FMD, %). A blood sample was analyzed for vascular endothelial growth factor (VEGF). Arterial blood flow (BF) and shear rate (SR) were measured during EX and CTRL during a typical treatment session. EX group has increased FMD% (+ 3.725%, p < 0.001), PLM ∆peak (+ 99.056 ml/min, p = 0.004), AUC (+ 37.359AU, p = 0.037) and VEGF (+ 8.825 pg/ml, p = 0.004). In the CTRL group, no difference between pre- and post-treatment was found for any variable. Increase in BF and SR was demonstrated during EX (BF + 123%, p < 0.05; SR + 134%, p < 0.05), but not during CTRL treatment. Exercise training improves peripheral vascular function in AD. These ameliorations may be due to the repetitive increase in SR during exercise which triggers NO and VEGF upregulation. This approach might be included in standard AD clinical practice as an effective strategy to treat vascular dysfunction in this population.

Identifiants

pubmed: 32728820
doi: 10.1007/s00421-020-04447-w
pii: 10.1007/s00421-020-04447-w
pmc: PMC7502067
doi:

Substances chimiques

Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2233-2245

Subventions

Organisme : PRIN
ID : PRIN 2010KL2Y73_004

Références

Clinics (Sao Paulo). 2008 Aug;63(4):479-82
pubmed: 18719758
Appl Physiol Nutr Metab. 2016 Aug;41(8):832-41
pubmed: 27441589
Front Physiol. 2018 Mar 14;9:169
pubmed: 29593548
J Physiol. 2012 Mar 15;590(6):1413-25
pubmed: 22310310
J Mol Cell Cardiol. 2018 May;118:46-69
pubmed: 29549046
J Alzheimers Dis. 2018;61(4):1599-1609
pubmed: 29376858
Aging Clin Exp Res. 2016 Dec;28(6):1169-1177
pubmed: 26661467
Int J Cardiol. 2014 Jul 15;175(1):21-9
pubmed: 24856805
Adv Physiol Educ. 2015 Jun;39(2):55-62
pubmed: 26031719
J Appl Physiol (1985). 2016 Oct 1;121(4):849-857
pubmed: 27516540
Sports Med. 1988 May;5(5):303-11
pubmed: 3387734
Acta Physiol (Oxf). 2015 Jul;214(3):349-60
pubmed: 25659833
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Brain Plast. 2018 Dec 12;4(1):65-79
pubmed: 30564547
Hypertension. 2010 May;55(5):1075-85
pubmed: 20351340
Ageing Res Rev. 2016 Jan;25:13-23
pubmed: 26607411
Aging (Albany NY). 2019 May 24;11(10):3138-3155
pubmed: 31127076
J Am Geriatr Soc. 2007 Oct;55(10):1613-7
pubmed: 17711428
Am J Physiol Heart Circ Physiol. 2016 Nov 1;311(5):H1277-H1286
pubmed: 27638879
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Alzheimers Dis. 2019;67(2):671-684
pubmed: 30636734
Curr Alzheimer Res. 2017 Jan 11;14(5):546 - 553
pubmed: 28078981
Hypertension. 2014 Feb;63(2):376-82
pubmed: 24277765
Exp Gerontol. 2008 Jun;43(6):499-504
pubmed: 18474414
J Physiol. 2015 Sep 1;593(17):3917-28
pubmed: 26108562
Microcirculation. 2001 Aug;8(4):207-20
pubmed: 11528529
Circulation. 2012 Nov 27;126(22):2625-35
pubmed: 23184282
Alzheimers Dement. 2019 Jan;15(1):158-167
pubmed: 30642436
Front Endocrinol (Lausanne). 2017 Dec 21;8:363
pubmed: 29312152
Psych J. 2015 Mar;4(1):38-46
pubmed: 26263529
Dement Geriatr Cogn Dis Extra. 2013 Aug 16;3(1):223-32
pubmed: 24052797
BMC Geriatr. 2018 May 22;18(1):120
pubmed: 29788900
Aging Cell. 2011 Dec;10(6):1032-7
pubmed: 21943306
J Alzheimers Dis. 2014;40(3):619-30
pubmed: 24503617
Postgrad Med J. 2006 Feb;82(964):101-5
pubmed: 16461472
J Cereb Blood Flow Metab. 2017 Aug;37(8):2649-2664
pubmed: 28617071
Neurology. 2019 Mar 19;92(12):e1322-e1330
pubmed: 30787164
J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S47-54
pubmed: 24337666

Auteurs

Anna Pedrinolla (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.

Massimo Venturelli (M)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy. massimo.venturelli@univr.it.
Department of Internal Medicine, University of Utah, Salt Lake, Utah, USA. massimo.venturelli@univr.it.

Cristina Fonte (C)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.
Department of Neurosciences, Biomedicine and Movement Sciences, Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Verona, Italy.

Stefano Tamburin (S)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.

Angela Di Baldassarre (A)

Department of Medicine and Aging Sciences, University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.

Fabio Naro (F)

Department of Anatomical, Histological, Forensic Medicine and Orthopedic Science, Rome, Italy.

Valentina Varalta (V)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.
Department of Neurosciences, Biomedicine and Movement Sciences, Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Verona, Italy.

Gaia Giuriato (G)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.

Barbara Ghinassi (B)

Department of Medicine and Aging Sciences, University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.

Ettore Muti (E)

Mons. A. Mazzali Foundation, Mantua, Italy.

Nicola Smania (N)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.
Department of Neurosciences, Biomedicine and Movement Sciences, Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Verona, Italy.

Federico Schena (F)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH